We have located links that may give you full text access.
Preliminary demonstration of a novel IOL power calculation: The O formula.
Journal of Cataract and Refractive Surgery 2022 June 2
PURPOSE: To evaluate the performance of a novel formula of intraocular lens (IOL) power calculation (O formula) based on ray-tracing without commonly used parameters including ultrasound compatible axial length, keratometry readings, and A constant.
SETTING: Tokyo Medical Center, Tokyo, Japan.
DESIGN: Retrospective consecutive case series.
METHODS: A total of 423 eyes (423 subjects) implanted with a single-piece, L-loop, acrylic IOL were enrolled. All biometric data for the O formula were obtained by anterior segment swept-source optical coherence tomography (SS-OCT) and SS-OCT-based biometer. The performance of the O formula was compared with those of the Barrett Universal II (BUII) and Kane formulas at 1 month postoperatively. Statistical analysis was applied according to a heteroscedastic test with standard deviation (SD) of prediction errors as the main parameter for formula performance.
RESULTS: The SD of the O formula (0.426) was significantly lower than that of the BUII (0.464, P = 0.034) but not significantly different from the Kane formula (0.433, P = .601). The percentages of patients with refractive prediction errors within ±0.50 and ±1.00 D of the O, BUII, and Kane formulas were 75.4 and 98.6%, 77.1 and 97.9%, and 76.6 and 98.1%, respectively.
CONCLUSIONS: The O formula, based on ray-tracing using SS-OCT-based devices, is one of the promising approaches for IOL power calculation, although additional larger-scale studies are needed. It may be used as an alternative in IOL power calculation because of its independence from commonly used parameters.
SETTING: Tokyo Medical Center, Tokyo, Japan.
DESIGN: Retrospective consecutive case series.
METHODS: A total of 423 eyes (423 subjects) implanted with a single-piece, L-loop, acrylic IOL were enrolled. All biometric data for the O formula were obtained by anterior segment swept-source optical coherence tomography (SS-OCT) and SS-OCT-based biometer. The performance of the O formula was compared with those of the Barrett Universal II (BUII) and Kane formulas at 1 month postoperatively. Statistical analysis was applied according to a heteroscedastic test with standard deviation (SD) of prediction errors as the main parameter for formula performance.
RESULTS: The SD of the O formula (0.426) was significantly lower than that of the BUII (0.464, P = 0.034) but not significantly different from the Kane formula (0.433, P = .601). The percentages of patients with refractive prediction errors within ±0.50 and ±1.00 D of the O, BUII, and Kane formulas were 75.4 and 98.6%, 77.1 and 97.9%, and 76.6 and 98.1%, respectively.
CONCLUSIONS: The O formula, based on ray-tracing using SS-OCT-based devices, is one of the promising approaches for IOL power calculation, although additional larger-scale studies are needed. It may be used as an alternative in IOL power calculation because of its independence from commonly used parameters.
Full text links
Related Resources
Trending Papers
Angiotensin Receptor Blocker-Neprilysin Inhibitor for Heart Failure with Reduced Ejection Fraction.Pharmacological Research : the Official Journal of the Italian Pharmacological Society 2024 May 12
Hemodynamic Support in Sepsis.Anesthesiology 2024 June 2
The Therapy and Management of Heart Failure with Preserved Ejection Fraction: New Insights on Treatment.Cardiac Failure Review 2024
European Respiratory Society Clinical Practice Guideline on symptom management for adults with serious respiratory illness.European Respiratory Journal 2024 May 9
Axillary Surgery for Breast Cancer in 2024.Cancers 2024 April 24
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app